AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2002 JAN 9 - (NewsRx.com & NewsRx.net) -- MedImmune, Inc. and Aviron have entered into a definitive merger agreement under which MedImmune plans to acquire Aviron and add Aviron's FluMist to its product offerings. The deal is anticipated to close in the first quarter 2002.
Hunein "John" Maassab invented FluMist after more than four decades of work at the University of Michigan School of Public Health. If approved, FluMist would represent a new approach to influenza vaccination: a nasal spray.
This summer, the US Food and Drug Administration's Vaccines and Related Biological Products Advisory Committee found that FluMist is effective, but asked for more information regarding safety. Aviron, which licensed the ...
Source: HighBeam Research, MedImmune Gets FluMist Rights In Agreement With Aviron.(Brief Article)